Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1250742

registered interest
date	11/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the annual per patient cost is to the NHS of inflammatory bowel disease.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	114172
answer	answer is ministerial correction date of answer 20/11/2020 answer text <p>This data is not held.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 114176 114189 question first answered 20/11/2020 09:30:46 answering member 4362 label Biography information for Edward Argar
tabling member	4131 label Biography information for Jim Shannon

1250743

registered interest
date	11/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Crohn's Disease and Ulcerative Colitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many patients have been diagnosed with (a) Crohn’s disease and (b) ulcerative colitis in (i) the East Midlands, (ii) the West Midlands, (iii) London, (iv) the North East, (v) the North West, (vi) the South East, (vii) the South West and (viii) Yorkshire and the Humber.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	114173
answer	answer is ministerial correction date of answer 20/11/2020 answer text <p>This data is not held in the format requested.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 114174 114175 114190 114191 question first answered 20/11/2020 09:25:14 answering member 4362 label Biography information for Edward Argar
tabling member	4131 label Biography information for Jim Shannon

1250744

registered interest
date	11/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Crohn's Disease and Ulcerative Colitis: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the average time taken is for a patient to be diagnosed with (a) Crohn’s disease and (b) ulcerative colitis in (i) the East Midlands, (ii) the West Midlands, (iii) London, (iv) the North East, (v) the North West, (vi) the South East, (vii) the South West and (viii) Yorkshire and the Humber.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	114174
answer	answer is ministerial correction date of answer 20/11/2020 answer text <p>This data is not held in the format requested.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 114173 114175 114190 114191 question first answered 20/11/2020 09:25:14 answering member 4362 label Biography information for Edward Argar
tabling member	4131 label Biography information for Jim Shannon

1250745

registered interest
date	11/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many inflammatory bowel disease patients have relapsed within a year of being diagnosed in (a) East Midlands, (b) West Midlands, (c) London, (d) North East, (e) North West, (f) South East, (g) South West and (h) Yorkshire and the Humber.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	114175
answer	answer is ministerial correction date of answer 20/11/2020 answer text <p>This data is not held in the format requested.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 114173 114174 114190 114191 question first answered 20/11/2020 09:25:15 answering member 4362 label Biography information for Edward Argar
tabling member	4131 label Biography information for Jim Shannon

1250746

registered interest
date	11/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the annual per patient cost to the NHS of patients with inflammatory bowel disease who have relapsed.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	114176
answer	answer is ministerial correction date of answer 20/11/2020 answer text <p>This data is not held.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 114172 114189 question first answered 20/11/2020 09:30:46 answering member 4362 label Biography information for Edward Argar
tabling member	4131 label Biography information for Jim Shannon

1250747

registered interest
date	11/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs and Medical Equipment: EU Law
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether, through the Medicines and Medical Devices Bill 2019-21, his Department plans to amend the definitions of (a) medicines, (b) medical devices and (c) biocides, as set out in Article 1 of Directive 2001/83/EC through the European Medicines Agency framework.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	114177
answer	answer is ministerial correction date of answer 24/11/2020 answer text <p>There are currently no plans to amend the definitions of medicines and medical devices through the Medicines and Medical Devices Bill. The Bill does not enable amendments to be made to the definition of ‘medicinal product’ in the Human Medicines Regulation 2012.The Bill does provide the powers to amend the definition in the Medical Devices Regulation 2002 for ‘medical device’, should a future need arise, for example to reflect innovative technologies not yet captured in the definition. Biocides are outside the scope of the Bill and are regulated by the Health and Safety Executive.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 24/11/2020 15:59:43 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4131 label Biography information for Jim Shannon

1250748

registered interest
date	11/11/2020
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Biocidal Products: Regulation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, whether the Health and Safety Executive will remain the competent authority for inspection and enforcement of biocide regulations after the transition period.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	114178
answer	answer is ministerial correction date of answer 18/11/2020 answer text <p>The competent authority role in relation to biocides approvals and authorisations formally rests with the Secretary of State and Ministers in the Devolved Administrations where appropriate. These functions are delegated by agreement to the Health and Safety Executive (HSE) and these arrangements will continue to apply for Great Britain after the transition period.</p><p> </p><p>HSE Northern Ireland (HSENI) will be the competent authority for Northern Ireland. HSE’s and HSENI’s role in inspection and enforcement will remain unchanged.</p> answering member constituency Mid Sussex answering member printed Mims Davies question first answered 18/11/2020 13:57:17 answering member 4513 label Biography information for Mims Davies
tabling member	4131 label Biography information for Jim Shannon

1250749

registered interest
date	11/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Negligence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many medication errors have occurred in the NHS in each of the last three years; and what steps his Department is taking to prevent those errors.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	114179
answer	answer is ministerial correction date of answer 24/11/2020 answer text <p>The number of medication related incidents reported to the National Reporting and Learning System (NRLS) as occurring in England in the last three years is shown in the following table. A patient safety incident is defined as any incident which could have, or did, harm a patient receiving National Health Service-funded care and is not synonymous with error. Incidents reported do not represent the actual number of incidents which may have occurred.</p><p> </p><table><tbody><tr><td><p>Reported incident type</p></td><td><p>April 2017 - March 2018</p></td><td><p>April 2018 - March 2019</p></td><td><p>April 2019 - March 2020</p></td><td><p>Total</p></td></tr><tr><td><p>Medication</p></td><td><p>204,162</p></td><td><p>216,177</p></td><td><p>222,514</p></td><td><p>642,853</p></td></tr></tbody></table><p> </p><p>Note:</p><p>The medication category represents approximately 10% of reported incidents per year. Incidents reported under other categories such as medical device incidents may also partly relate to medication – for example when medication is given via a medical device. This data is publicly available at the following link:</p><p><a href="https://www.england.nhs.uk/patient-safety/national-patient-safety-incident-reports/" target="_blank">https://www.england.nhs.uk/patient-safety/national-patient-safety-incident-reports/</a></p><p>The Medicines Safety Improvement Board continues to work to deliver the recommendations of the Short Life Working Group (SLWG), which advised on how to improve safety in the use of medicines. A review of the progress against the recommendations of the SLWG is being conducted on behalf of the National Director of Patient Safety and is expected to report to the Medicines Safety Improvement Board in December.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 24/11/2020 15:32:18 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4131 label Biography information for Jim Shannon

1250750

registered interest
date	11/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs: Safety
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on implementing the recommendations of the Short Life Working Group on reducing medication-related harms; and if he will reconvene the group to identify a five-year future plan.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	114180
answer	answer is ministerial correction date of answer 24/11/2020 answer text <p>The Medicines Safety Improvement Board continues to work to deliver the recommendations of the Short Life Working Group (SLWG) which advised on how to improve safety in the use of medicines.</p><p>A review of the progress against the recommendations of the SLWG is being conducted on behalf of the National Director of Patient Safety and is expected to report to the Medicines Safety Improvement Board in December.</p><p>The Department has no plans to reconvene the SLWG on reducing medication-related harms. Medication harm is included in the 10-year National Health Service National Patient Safety Strategy.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 24/11/2020 15:28:44 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4131 label Biography information for Jim Shannon

1250751

registered interest
date	11/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs: Safety
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his Department’s five-year strategy is for tackling medication errors and medication-related harms in the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	114181
answer	answer is ministerial correction date of answer 24/11/2020 answer text <p>Medication errors and medication-related harms in the National Health Service are included in the 10-year NHS Patient Safety Strategy, which was published in July 2019.</p><p>Within this Strategy, the Medicines Safety Improvement Board is working to reduce medication errors and harms in the NHS, focusing on high risk drugs, situations and vulnerable patients. Work already underway includes the accelerated rollout of electronic prescribing in hospitals, monitoring higher risk prescribing practice linked to hospital admissions, and deploying more clinical pharmacists into primary care and care homes.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 24/11/2020 15:18:09 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4131 label Biography information for Jim Shannon